title: How can I predict bleeding in my elderly patient taking anticoagulants?
authors.affiliation: Clinical and Research Fellow, Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA.|Fellow in Patient Safety and Quality, Harvard Medical School, Boston, MA, USA.
authors.forename: Gene R
authors.initials: GR
authors.lastname: Quinn
authors.affiliation: Associate Professor of Medicine, Division of Hospital Medicine, University of California, San Francisco, San Francisco, CA, USA. E-mail: mfang@medicine.ucsf.edu.
authors.forename: Margaret C
authors.initials: MC
authors.lastname: Fang
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy; D005260:Female; D015577:Geriatric Assessment / Q000379:methods*; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced; D008297:Male; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000188:drug therapy
chemical_list: D000925:Anticoagulants